Tempsens Instruments (India) Q2 FY27 Results: Consolidated Net Profit ₹19.44 Crore on Total Income of ₹139 Crore
Earnings
Industrial products
Blacklitt Research3 min read
Tempsens Instruments (India) reported consolidated total income of ₹138.54 crore and net profit of ₹19.44 crore for the quarter ended 30 Sep 2026, it said in a filing on 30 Oct 2026. Standalone total income was ₹117.63 crore and net profit ₹16.14 crore for the same quarter.
Key highlights
Consolidated
Including its subsidiaries
Total income: ₹138.54 crore, up 33.1% YoY and 14.6% QoQ
Net profit: ₹19.44 crore, up 20.2% YoY and 19.5% QoQ
EPS: Basic ₹2.26, against ₹1.88 a year earlier and ₹1.88 in Q1 FY27
Tax expense: ₹3.71 crore, down 29.9% YoY from ₹5.30 crore
Standalone
The company on its own, without its subsidiaries
Total income: ₹117.63 crore, up 19.2% YoY and 13.0% QoQ
Net profit: ₹16.14 crore, up 19.9% YoY and 24.8% QoQ
EPS: Basic ₹1.98, against ₹1.67 a year earlier and ₹1.60 in Q1 FY27
Tax expense: ₹2.92 crore, down 38.1% YoY from ₹4.72 crore
Summary
Consolidated ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
138.54
104.08
+33.1%
120.87
+14.6%
Revenue from operations
136.32
101.71
+34.0%
118.71
+14.8%
Other income
2.23
2.37
-6.1%
2.16
+3.0%
19.44
16.17
+20.2%
16.27
+19.5%
Profit before tax
23.13
21.46
+7.8%
21.39
+8.1%
Finance costs
1.11
1.22
-9.1%
1.36
-18.2%
Depreciation
4.08
3.41
+19.9%
3.85
+6.1%
Tax expense
3.71
5.30
-29.9%
5.22
-28.9%
Net profit margin
14.03%
15.53%
-1.50 pp
13.46%
+0.57 pp
EPS, basic (₹)
2.26
1.88
+20.2%
1.88
+20.2%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Revenue from operations rose 34.0% year on year to ₹136.32 crore, while other income fell 6.1% to ₹2.23 crore, or 1.6% of total income this quarter.
Net profit rose 20.2%, slower than total income at 33.1%, and profit before tax rose 7.8% to ₹23.13 crore. Tax expense fell 29.9% to ₹3.71 crore. That makes the tax charge 16.0% of profit before tax this quarter, against 24.7% in the year-earlier quarter.
Of the ₹19.44 crore consolidated net profit, ₹18.43 crore is attributable to owners of the parent and ₹1.01 crore to non-controlling interests. Profit includes the company's share of net profit of a joint venture accounted for under the equity method.
Finance costs fell 9.1% to ₹1.11 crore, or 0.8% of total income, while depreciation rose 19.9% to ₹4.08 crore. The auditors' review report on the consolidated results is unmodified. It notes that the comparative quarter ended 30 Sep 2025 was approved by the board but not subjected to audit or review, and that six subsidiaries' interim results were reviewed by other auditors.
Standalone ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
117.63
98.69
+19.2%
104.12
+13.0%
Revenue from operations
115.68
96.58
+19.8%
101.85
+13.6%
Other income
1.95
2.11
-7.7%
2.27
-14.0%
16.14
13.47
+19.9%
12.93
+24.8%
Profit before tax
19.06
18.18
+4.8%
17.25
+10.5%
Finance costs
1.04
1.17
-11.1%
1.28
-19.2%
Depreciation
3.58
3.27
+9.4%
3.40
+5.1%
Tax expense
2.92
4.72
-38.1%
4.32
-32.5%
Net profit margin
13.72%
13.64%
+0.08 pp
12.42%
+1.30 pp
EPS, basic (₹)
1.98
1.67
+18.6%
1.60
+23.7%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone revenue from operations rose 19.8% year on year to ₹115.68 crore, and total income rose 19.2% to ₹117.63 crore. Other income fell 7.7% to ₹1.95 crore, or 1.7% of total income.
Standalone net profit rose 19.9% to ₹16.14 crore, faster than total income. Profit before tax rose only 4.8% to ₹19.06 crore, while tax expense fell 38.1% to ₹2.92 crore.
Consolidated net profit grew 20.2% year on year, slightly faster than standalone at 19.9%, but grew 19.5% quarter on quarter, slower than standalone at 24.8%.
The standalone auditors' review report is unmodified. The comparative quarter ended 30 Sep 2025 was approved by the board but not subjected to audit or review.
Inference
The fresh issue of ₹95.00 crore and the offer for sale of ₹555.00 crore were the two parts of the issue. As on 30 Sep 2026, ₹55.61 crore of the net IPO proceeds had been utilised and ₹31.66 crore remained unutilised.
The board appointed Aryan Rathi as an Additional Director, designated Executive Director cum Lead-Global Sales, for five years from 30 Oct 2026, subject to shareholder approval. Ankit Talesra resigned as Non-Executive Director with effect from 30 Oct 2026, citing personal reasons. P C Modi & Co was appointed Joint Statutory Auditor until the ensuing AGM, subject to approval by postal ballot. The board also approved ratifying the Tempsens Instruments Employees Stock Option Plan 2025, under which 347,100 options had been granted and 13,544 had lapsed as on 30 Oct 2026, leaving 1,252,676 available for grant.
The filing does not state the reason for Ankit Talesra's resignation beyond the personal reasons in his letter, the remuneration or fees payable to P C Modi & Co, or whether Aryan Rathi's terms change beyond his designation.
Create a free account to read the rest of this article and the analysis that follows.
By continuing you agree to our Terms and Privacy Policy, and to receive updates from Blacklitt by email. You can unsubscribe anytime.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
TEMPSENSTempsens Instruments (India) Ltd.